ERBB2 and breast carcinoma: In primary breast cancer, the overall 5-year cumulative incidence of BM is 1.7%, 0.1% for luminal A, 3.3% for luminal B, 3.7% for HER2-positive, and 7.4% for TNBC [11] (Table 1).